Company Name | Civitas Therapeutics |
---|---|
Website | www.acorda.com |
Snippet | By clicking "Ok", you will be leaving this website (sponsored by Acorda Therapeutics, Inc.) to enter an external and entirely independent website. Acorda.com provides this … |
Type | Public |
Country | united states |
Founded | 1995 |
Founder | Ron Cohen |
Revenue | US$588.22 Million (FY 2017)[2] |
Website | Acorda.com |
Industry | Health careBiotechnology |
Products | ZanaflexAmpyraQutenza |
linkedin.com/company/civitas-therapeutics | |
Traded as | NASDAQ: ACORS&P 600 ComponentFWB: CDG |
Key people | Ron Cohen (CEO)Andrew R. Blight |
Net income | US$30.6 Million (FY 2011)[2] |
size_range | 11 - 50 |
Headquarters | Ardsley, New York, United States |
Total assets | US$379.5 Million (FY 2011)[2] |
Total equity | US$205.2 Million (FY 2011)[2] |
Operating income | US$35.1 Million (FY 2011)[2] |
Number of employees | 328 (February, 2012) [2] |
Civitas Therapeutics is part of the United States company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us